RHO Ventures VI LP, 10% Owner at Cara Therapeutics, Inc. (CARA), bought 800,000 shares at $4.93 ($3.9M) on 2016-03-17, disclosed to the SEC on 2016-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.78 | 152,273 | $728K | 18.7% |
| 2 | $4.78 | 152,273 | $728K | 18.7% |
| 3 | $4.93 | 247,727 | $1.2M | 31.3% |
| 4 | $4.93 | 247,727 | $1.2M | 31.3% |
| Total | $4.87 avg | 800,000 | $3.9M | 100% |